Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOX: Intranasal Oxytocin for Bone Health in Children With ASD
NCT05754073Phase 2Recruiting
- Start
- Aug 2023
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxytocin nasal spray in low bone mineral density (2 arms). Primary endpoint: Whole body less head bone mineral density Z-scores at 12 months. Started Aug 2023; status: recruiting.
02
Drugs
oxytocin nasal spray
03
Conditions
low bone mineral density
Beyond the preview
Go deeper on NCT05754073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05754073.